Drug Eluting Stent
Sirolimus-Eluting Coronary Stent System with Bio-Absorbable Polymer Coating with highly powerful medication for avoiding thrombotic and re-stenotic occurrences
People
Description
Polylactic-co-glycolic acid (PLGA), which completely breaks down into carbon dioxide and water, is a component of the biodegradable polymer.
No additional auxiliary polymer, such as parylene C, is required for the Sirolimus-Eluting Coronary Stent Implantation System.
In less than three months, Sirolimus is released from the controlled polymer degradation, which is intended to end simultaneously. This is specifically tuned to the numerous immune response reactions that happen following stent placement and covers the period of time when the medicine is most needed. We refer to this as RapasorbTM Technology.
No additional auxiliary polymer, such as parylene C, is required for the Sirolimus-Eluting Coronary Stent Implantation System.
In less than three months, Sirolimus is released from the controlled polymer degradation, which is intended to end simultaneously. This is specifically tuned to the numerous immune response reactions that happen following stent placement and covers the period of time when the medicine is most needed. We refer to this as RapasorbTM Technology.
